BLADE, the company formerly known as HDT Global, has been awarded a contract supporting the Critical Equipment Decontamination System (CEDS) program for U.S. Special Operations Forces. The company disclosed the award on October 12, 2026, from its base in Solon, Ohio. The contract advances BLADE's work on the large CEDS variant, a transportable equipment decontamination system built to restore mission-essential gear exposed to chemical and biological agents.
What the contract covers
The award is tied to the large variant of CEDS. BLADE describes that variant as transportable, which sets it apart from fixed installations. Its stated purpose is to decontaminate sensitive operational equipment so that it can be used again after exposure to chemical or biological agents.
BLADE did not state the value of the contract, the period of performance, or the number of systems involved. It also did not say whether the work covers design, development, testing or production. The company's wording is that the award advances its work on the large variant, which points to continuing development rather than a finished fielded product. The announcement does not confirm that reading, so it should be treated as an inference from the phrasing.
Who runs the program
CEDS is led by the Joint Project Manager for CBRN Special Operation Forces, known as JPM CBRN SOF. That office sits under the Portfolio Management Executive Chemical, Biological, Radiological and Nuclear Defense, or PME CBRND. The program is intended to strengthen the operational readiness and survivability of U.S. Special Operations Forces.
The chain of command matters for understanding the customer. The program office is dedicated to special operations rather than to the wider force. Its requirements reflect the conditions those units work in, which BLADE describes as austere, hostile and contested environments.
The operational problem
BLADE frames the system around recovery and reuse. Equipment that has been exposed to chemical or biological agents can be hazardous to handle and may be unfit for service. A system that decontaminates it lets units recover critical assets safely and put them back into use.
The company lists three intended effects. The system is meant to reduce logistical burdens, preserve essential resources and speed the return of equipment to operational service. All three are design intentions. BLADE gave no performance data, such as which agents the system handles, how long a cycle takes, what categories of equipment it accepts or how much it weighs.
Tim Stickler, Sr. Director of CBRN Integrated Protection, Bio & Chemical Security at BLADE, said the award reflects the company's commitment to protecting warfighters and improving mission readiness. He said CEDS lets Special Operations Forces recover essential equipment, sustain operations and keep their advantage in contested environments.
What this means for the field
The announcement is a procurement milestone, and the facts in it are limited. Several observations follow from what is and is not stated.
First, the focus is on equipment rather than people. Much public attention on chemical and biological defense goes to protective clothing, detection and personnel decontamination. CEDS addresses sensitive operational equipment, which can include items that cannot simply be washed or discarded. The program's premise is that returning such items to service is worth a dedicated, transportable system. That premise is reasonable given the stated aim of cutting logistical burden, but the announcement offers no figures to test it.
Second, nothing in the announcement describes a robot. BLADE does not say the large CEDS variant uses automation, manipulators or remote operation. For a robotics readership, the relevance is indirect. Contaminated environments are a recognized use case for unmanned systems, because they keep people away from hazards. Whether CEDS includes any such capability is unknown. Readers should not assume it does.
Third, comparison with other systems is not possible from the facts given. The announcement provides no capacity, throughput, power requirement, crew size or setup time for the large variant. It also does not describe how it differs from a smaller variant, although the phrase large variant implies that at least one other configuration exists in the program. Without those details, any claim that CEDS is faster, lighter or more capable than existing decontamination equipment would be unsupported.
Fourth, several things remain unproven. The system's effectiveness against specific agents has not been shown publicly. The claims about reduced logistics and faster return to service are stated goals, not measured results. The contract's scope is not defined, so it is unclear how close the large variant is to fielding.
What the award does establish is narrower. A U.S. special operations program office has chosen to continue work with BLADE on a transportable decontamination capability for critical equipment. That is a signal of sustained requirement in this niche, and it ties BLADE's CBRN business to a named program with a named management chain. Further disclosures on testing, delivery or the scope of the contract would show whether the work leads to fielded systems.
